UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hormonal Regulation of Response to Oxidative Stress in Insects-An Update

International Journal of Molecular Sciences, 2015-10, Vol.16 (10), p.25788-25816

2015

Volltextzugriff (PDF)

Impact of Concomitant Medication Administered at the Time of Initiation of Nivolumab Therapy on Outcome in Non-small Cell Lung Cancer

Anticancer research, 2020-04, Vol.40 (4), p.2209-2217

2020

Volltextzugriff (PDF)

Role of adipokinetic hormone and adenosine in the anti-stress response in Drosophila melanogaster

Journal of insect physiology, 2016-08, Vol.91-92, p.39-47

2016

Volltextzugriff (PDF)

Chronic Inflammation as a Potential Predictive Factor of Nivolumab Therapy in Non-small Cell Lung Cancer

Anticancer research, 2018-12, Vol.38 (12), p.6771-6782

2018

Volltextzugriff (PDF)

Pharmacokinetics and safety of rucaparib in patients with advanced solid tumors and hepatic impairment

Cancer chemotherapy and pharmacology, 2021-08, Vol.88 (2), p.259-270

2021

Volltextzugriff (PDF)

PET/CT-tailored treatment of locally advanced oesophago-gastric junction adenocarcinoma: a report on the feasibility of the multicenter GastroPET study

Therapeutic advances in medical oncology, 2021-12, Vol.13, p.17588359211065153

2021

Volltextzugriff (PDF)

MiR-205 functions as a tumor suppressor in adenocarcinoma and an oncogene in squamous cell carcinoma of esophagus

Tumor biology, 2016-06, Vol.37 (6), p.8007-8018

2016

Volltextzugriff (PDF)

Diagnostic and prognostic potential of miR-21, miR-29c, miR-148 and miR-203 in adenocarcinoma and squamous cell carcinoma of esophagus

Diagnostic pathology, 2015-04, Vol.10 (1), p.42-42, Article 42

2015

Volltextzugriff (PDF)

Plasma Phosphatidylcholines Fatty Acids in Men with Squamous Cell Esophageal Cancer: Chemoradiotherapy Improves Abnormal Profile

Medical science monitor, 2016-10, Vol.22, p.4092-4099

2016

Volltextzugriff (PDF)

Utilization and efficacy of second-line targeted therapy in metastatic renal cell carcinoma: data from a national registry

BMC cancer, 2017-12, Vol.17 (1), p.880-880, Article 880

2017

Volltextzugriff (PDF)

Poikilothermic traits in Mashona mole-rat (Fukomys darlingi). Reality or myth?

Journal of thermal biology, 2012-11, Vol.37 (7), p.485-489

2012

Volltextzugriff (PDF)

Real‐life effectiveness of first‐line anticancer treatments in stage IIIB/IV NSCLC patients: Data from the Czech TULUNG Registry

Thoracic cancer, 2020-11, Vol.11 (11), p.3346-3356

2020

Volltextzugriff (PDF)

Treatment patterns and real-world evidence for stage III non-small cell lung cancer in Central and Eastern Europe

Radiology and oncology, 2020-10, Vol.54 (4), p.447-454

2020

Volltextzugriff (PDF)

Care of patients with non-small-cell lung cancer stage III – the Central European real-world experience

Radiology and oncology, 2020-05, Vol.54 (2), p.209-220

2020

Volltextzugriff (PDF)

Circulating tumor cells: what we know, what do we want to know about them and are they ready to be used in clinics?

American journal of translational research, 2017-01, Vol.9 (6), p.2807-2823

2017

Volltextzugriff (PDF)

Serum adiponectin relates to shortened overall survival in men with squamous cell esophageal cancer treated with preoperative concurrent chemoradiotherapy: a pilot study

Medical science monitor, 2014-11, Vol.20, p.2351-2357

2014

Volltextzugriff (PDF)

Autologous dendritic cell-based immunotherapy (DCVAC/LuCa) and carboplatin/paclitaxel in advanced non-small cell lung cancer: A randomized, open-label, phase I/II trial

Cancer treatment and research communications, 2021, Vol.28, p.100427-100427, Article 100427

2021

Volltextzugriff (PDF)

Efficacy of everolimus in second- and third-line therapy for metastatic renal cell carcinoma: A registry-based analysis

Urologic oncology, 2014-07, Vol.32 (5), p.569-575

2014

Volltextzugriff (PDF)

Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: a phase III randomized trial

Lung cancer (Amsterdam, Netherlands), 2003-09, Vol.41 (3), p.321-331

2003

Volltextzugriff (PDF)

Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

The Lancet (British edition), 2019-11, Vol.394 (10212), p.1929-1939

2019

Volltextzugriff (PDF)

Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial

The lancet oncology, 2021-01, Vol.22 (1), p.51-65

2021

Volltextzugriff (PDF)

419. PROGNOSTIC RELEVANCE OF METABOLIC RESPONSE TO NEOADJUVANT CHEMOTHERAPY FOR ADENOCARCINOMA OF THE ESOPHAGUS AND ESOPHAGOGASTRIC JUNCTION

Diseases of the esophagus, 2023-08, Vol.36 (Supplement_2)

2023

Volltextzugriff (PDF)

Randomized Phase III Trial of Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma

Journal of clinical oncology, 2017-12, Vol.35 (35), p.3916-3923

2017

Volltextzugriff (PDF)

Access to Novel Drugs for Non‐Small Cell Lung Cancer in Central and Southeastern Europe: A Central European Cooperative Oncology Group Analysis

The oncologist (Dayton, Ohio), 2020-03, Vol.25 (3), p.e598-e601

2020

Volltextzugriff (PDF)

1 – 25 von 85

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(80)
Mit Volltextzugriff
(81)

Publikationsform

Artikel
(84)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(41)
Science & Technology
(41)
Humans
(30)
Oncology
(29)
Middle Aged
(25)
Female
(24)
Male
(24)
Aged
(23)
Adult
(18)
Lung Cancer
(11)
Lung Neoplasms - Drug Therapy
(11)
Patients
(11)
Renal Cell Carcinoma
(10)
Retrospective Studies
(10)
Small Cell Lung Carcinoma
(9)
Survival
(9)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(8)
Carcinoma, Renal Cell - Drug Therapy
(8)
Chemotherapy
(8)
Metastasis
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Thoracic Oncology
(11)
Journal Of Clinical Oncology
(9)
Anticancer Research
(6)
Lung Cancer
(6)
Anticancer Research/anticancer Research
(4)
Klinická Onkologie
(3)
Onkologie
(3)
Urologic Oncology
(3)
Cancers
(2)
Chest
(2)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Hormonal Regulation of Response to Oxidative Stress in Insects-An Update

Impact of Concomitant Medication Administered at the Time of Initiation of Nivolumab Therapy on Outcome in Non-small Cell Lung Cancer

Role of adipokinetic hormone and adenosine in the anti-stress response in Drosophila melanogaster

Chronic Inflammation as a Potential Predictive Factor of Nivolumab Therapy in Non-small Cell Lung Cancer

Pharmacokinetics and safety of rucaparib in patients with advanced solid tumors and hepatic impairment

PET/CT-tailored treatment of locally advanced oesophago-gastric junction adenocarcinoma: a report on the feasibility of the multicenter GastroPET study

MiR-205 functions as a tumor suppressor in adenocarcinoma and an oncogene in squamous cell carcinoma of esophagus

Diagnostic and prognostic potential of miR-21, miR-29c, miR-148 and miR-203 in adenocarcinoma and squamous cell carcinoma of esophagus

Plasma Phosphatidylcholines Fatty Acids in Men with Squamous Cell Esophageal Cancer: Chemoradiotherapy Improves Abnormal Profile

Utilization and efficacy of second-line targeted therapy in metastatic renal cell carcinoma: data from a national registry

Poikilothermic traits in Mashona mole-rat (Fukomys darlingi). Reality or myth?

Real‐life effectiveness of first‐line anticancer treatments in stage IIIB/IV NSCLC patients: Data from the Czech TULUNG Registry

Treatment patterns and real-world evidence for stage III non-small cell lung cancer in Central and Eastern Europe

Care of patients with non-small-cell lung cancer stage III – the Central European real-world experience

Circulating tumor cells: what we know, what do we want to know about them and are they ready to be used in clinics?

Serum adiponectin relates to shortened overall survival in men with squamous cell esophageal cancer treated with preoperative concurrent chemoradiotherapy: a pilot study

Autologous dendritic cell-based immunotherapy (DCVAC/LuCa) and carboplatin/paclitaxel in advanced non-small cell lung cancer: A randomized, open-label, phase I/II trial

Efficacy of everolimus in second- and third-line therapy for metastatic renal cell carcinoma: A registry-based analysis

Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: a phase III randomized trial

Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial

419. PROGNOSTIC RELEVANCE OF METABOLIC RESPONSE TO NEOADJUVANT CHEMOTHERAPY FOR ADENOCARCINOMA OF THE ESOPHAGUS AND ESOPHAGOGASTRIC JUNCTION

Randomized Phase III Trial of Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma

Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma: Final Overall Survival Analysis of the Phase 3 PROTECT Trial

Access to Novel Drugs for Non‐Small Cell Lung Cancer in Central and Southeastern Europe: A Central European Cooperative Oncology Group Analysis

Suchergebnisse filtern